Company
United StatesPublic company, NYSE: DGXQuest Diagnostics (NYSE: DGX), Teterboro, NJ – FDA Inspections
Inspection records and compliance data for Quest Diagnostics in Teterboro, New Jersey. 1 FDA inspection on record, last inspected November 10, 2009. Publicly traded as NYSE: DGX.
Company Profile
This profile covers Quest Diagnostics based in Teterboro, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected November 10, 2009.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 10, 2009 | VAI | Medical Devices & Rad Health · Bioresearch Monitoring | 624765 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Quest Diagnostics
Stock ticker
DGX
Exchange
NYSE
Share price
$254.20
Market cap
$28.0B
Price as of
November 6, 2026
FEI Number
1000129825
Address
1 Malcolm Ave, Teterboro, New Jersey 07608, United States
Country
United States
ID: 40940d3b-e89a-4c7d-b588-8f5c379988df